Comments
Loading...

Salarius Pharmaceuticals

SLRXNASDAQ
Logo brought to you by Benzinga Data
$2.69
0.072.67%
At close: -
$2.73
0.041.35%
After Hours: Jan 17, 7:41 PM EDT
Decoy Therapeutics, Inc announced it will be merged with Salarius Pharmaceuticals (SLRX) on Monday, January 13, 2025

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock, Short Interest Report

Short interest in Salarius Pharmaceuticals Inc (NASDAQ:SLRX) increased during the last reporting period, rising from 26.34K to 31.11K. This put 2.18% of the company's publicly available shares short.

Short interest for Salarius Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Salarius Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 136.27K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.

Short Interest
31.11K
Short Interest %
2.18%
Days to Cover
1
Data brought to you by Benzinga APIs

Looking for the most shorted stocks?

People Also Watch